In Brief: BASF
This article was originally published in The Tan Sheet
Executive Summary
BASF: Submits additional safety data in support of its 1989 citizen's petition requesting that the agency consider including Uvinul P25 as a Category I ingredient in the sunscreen monograph in an Oct. 12 letter to FDA. The letter cites new data from animal, in vitro and photomutagenicity tests. In a February 4, 1994 letter to FDA, BASF complained about the agency's failure to address its petition ("The Tan Sheet," Feb. 14, 1994, p. 11)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning